Clinical trial Recruiting at 1 site Observational

Disparities in Mental Health Screening and Support for Cancer Patients and Families

Official title: ALTHEA - tAckLing menTal Health Cancer Patients and Their Families: Digital Solutions for bEtter cAre Work Package 3: Disparities in Mental Health Screening and Support

Run by European Institute of Oncology · NCT07691281 · Data updated 2026-11-12

This study tests whether cancer patients and their families across Europe have equal access to mental health screening and support services.

More Mental Health trials

Quick facts

Study typeObservational
SexAll
Enrollment2000 (estimated)
SponsorEuropean Institute of Oncology
Academic / other
Locations1 site (Milan, Mi)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedOctober 15, 2026
Study endsDecember 30, 2026
Registry record updatedSeptember 10, 2026
Trial IDNCT07691281 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with cancer (any stage, undergoing treatment, or survivors) and their caregivers living in the EU who can access the internet and consent to participate; includes pediatric patients (12-17) and corresponding caregivers as described.

Probably not a fit

Patients not experiencing barriers to mental health screening or without internet access may see limited or no direct benefit from the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational effort will collect online surveys from cancer patients, survivors, and their caregivers across diverse EU regions to identify disparities in access to mental health screening and psychological-cognitive support. The study plans to enroll at least 1,000 patients and 1,000 family members or caregivers, including pediatric subgroups, to understand experiences, barriers, and facilitators in mental health care. Participants must reside in the EU, have internet access, and be able to provide informed consent. Pediatric participation includes adolescents aged 12-17 acting for themselves and caregivers representing younger children. The protocol focuses on survey-based data collection without specified interventions.

Why it matters

Potential benefit: Findings could guide improvements in how mental health screening and psychosocial support are offered to cancer patients and their families.

How similar studies have gone: Previous research in similar populations has identified disparities in access to psychosocial services, suggesting potential for meaningful insights in this EU-wide effort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for patients:

* residence in EU
* internet access
* access to a technological device for survey participation
* individuals at all cancer stages who have been diagnosed with cancer, are currently undergoing treatment or have survived cancer
* ability to understand and the willingness to sign a written informed consent document

Inclusion Criteria for family members and caregivers:

* residence in EU
* internet access
* access to a technological device for survey participation
* individuals that are aged 18 or older who currently provide, or have provided, care, psychosocial and physical support for a cancer patient in the EU
* ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

* NA

Where it's running

  • European Institute of Oncology, Milan
    Milan, Mi, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.